In our present study, we assessed an unknown clinical significance, specific tumor suppressor role and molecular mechanism of SOX30 in different subtype NSCLC using clinical association analysis, prognostic analysis and differentially expressed cell models. The gene discussed is SOX30; the disease is neoplasm.